Cambridge Associates LLC Exact Sciences Corp Transaction History

Cambridge Associates LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$57.56 - $82.54 $655,550 - $940,048	-11,389 Closed	0 $0
Q4 2021 Sep 06, 2022	SELL	$72.5 - $100.68 $39,295 - $54,568	-542 Reduced 4.54%	11,389 $886,000
Q4 2021 May 10, 2022	BUY	$72.5 - $100.68 $864,997 - $1.2 Million	11,931 New	11,931 $929,000
Q4 2021 Feb 11, 2022	SELL	$72.5 - $100.68 $825,702 - $1.15 Million	-11,389 Closed	0 $0
Q3 2021 Dec 20, 2022	BUY	$90.24 - $124.05 $1.08 Million - $1.48 Million	11,931 New	11,931 $1.13 Million
Q3 2021 Sep 06, 2022	SELL	$90.24 - $124.05 $48,910 - $67,235	-542 Reduced 4.54%	11,389 $1.09 Million
Q3 2021 May 10, 2022	BUY	$90.24 - $124.05 $1.08 Million - $1.48 Million	11,931 New	11,931 $1.13 Million

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Cambridge Associates LLC , based on Form 13F filings with the SEC.

Stay updated on Cambridge Associates LLC with notifications on news.